Clinical Trial: Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications

Article

This trial aims to explore whether or not their is a relationship between inflammation and obesity in asthma patients and how this relationship can impact a patient's response to treatment.

Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications

Study Type: Observational

Age/Gender Requirement: 18 years+ (male/female)

Sponsor: National Heart, Lung, and Blood Institute

Purpose: To “examine the relationship between obesity and inflammation and the effect they have on response to corticosteroid asthma medications.”

Related Videos
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Solutions to Prevent Climate Change-Related Illness, with Janelle Bludhorn, PA-C
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
Mikkael Sekeres, MD:
© 2024 MJH Life Sciences

All rights reserved.